The Journal of Organic Chemistry
Article
(d3-2a). HRMS (ESI): m/z calcd for [M + NH4]+ C30H30D3N2O6S2
584.1963, found 584.1958. 1H NMR (400 MHz, CDCl3) δ: 7.99 (2H,
d, J = 8.3), 7.77 (1H, d, J = 7.9), 7.57 (1H, s), 7.54−7.46 (1H, m),
7.45−7.40 (2H, m), 7.33 (2H, d, J = 8.1), 7.25 (2H, d, J = 8.3), 7.00
(2H, d, J = 8.1), 6.87 (1H, s), 4.60 (2H, br s), 4.50 (1H, s), 4.01 (3H,
the signal of the proton at 5. 95 ppm and the signal of the methyl
protons at 2.55 ppm.
Methyl 2-{N-[2-(3-{[(4-Methylbenzene)sulfonyl]methyl}-
naphthalen-2-yl)ethyl](4-methylbenzene)sulfonamido}prop-2-
enoate (19). HRMS (ESI): m/z calcd for [M + NH4]+ C31H35N2O6S2
595.1931, found 595.1928. 1H NMR (400 MHz, CDCl3) δ: 7.73 (1H,
d, J = 8.0), 7.69−7.66 (1H, m), 7.68 (1H, superimposed s), 7.66 (1H,
superimposed s, CHar), 7.62 (2H, d, J = 8.5), 7.59 (2H, d, J = 8.5),
7.50−7.41 (2H, m), 7.26 (2H, d, J = 8.0), 7.23 (2H, d, J = 8.0), 6.44
(1H, s), 5.81 (1H, s), 4.49 (2H, br s), 3.65 (3H, s), 3.64−3.60 (2H,
m), 2.97−2.93 (2H, m), 2.43 (3H, s), 2.43 (3H, s). 13C NMR (100
MHz, CDCl3) δ: 164.3, 145.0, 143.8, 136.0, 135.7, 135.2, 133.5, 132.6,
132.1, 129.8 (2 × C), 129.6 (2 × C), 129.2, 128.8, 128.7 (2 × C),
127.8 (2 × C), 127.7, 127.2, 127.0, 126.2, 124.8, 59.6, 52.6, 50.3, 32.5,
21.8, 21.7. One carbon is missing probably due to overlapping.
Rearrangement of (R)-20. (R)-20 (100 mg, 0.21 mmol) and GA-
SBA-15 (29 mg, 0.04 mmol) were dissolved in benzene (10 mL). The
mixture was heated at 80 °C for 16.5 h. The solvent was removed in
vacuo, and the residue was purified by flash chromatography on silica
gel (pentane/AcOEt, 80/20 to 50/50). This led to (2S,3R)-21 (24 mg,
24%) as a yellow amorphous solid and 22 (40 mg, 40%) as a yellow
amorphous solid.
2
s), 2.44 (3H, s), 2.33 (3H, s). H NMR (61.4 MHz, acetone) δ 1.67
(br s).
Methyl 2-{N-[(3-{[(4-Methylbenzene)sulfonyl](2H1)methyl}-
naphthalen-2-yl)methyl](4-methylbenzene)sulfonamido}(2H2)-
prop-2-enoate (d3-3a). HRMS (ESI): m/z calcd for [M + NH4]+
C30H30D3N2O6S2 584.1963, found 584.1961. 1H NMR (400 MHz,
CDCl3) δ: 7.88 (2H, d, J = 8.3), 7.77 (1H, s), 7.77−7.72 (3H,
superimposed m), 7.69−7.64 (1H, m), 7.52−7.45 (2H, m), 7.43 (1H,
s), 7.37−7.32 (4H, 2 superimposed d, J = 8.1), 4.84 (1H, s), 4.77 (2H,
2
s), 3.53 (3H, s), 2.48 (3H, s), 2.47 (3H, s). H NMR (61.4 MHz,
acetone) δ: 6.15 (br s), 5.63 (br s), 5.00 (br s).
Rearrangement of ( )-13. (CH2O)n (26 mg, 0.88 mmol), CuI
(34 mg, 0.18 mmol), 1,4-dioxane (1 mL), enediyne ( )-13 (100 mg,
0.35 mmol), and dicylohexylamine (115 mg, 0.63 mmol) were added
sequentially into a flask equipped with a reflux condenser under an
argon atmosphere. The resulting mixture was stirred at reflux for 2 h.
Solvent was evaporated under vacuo, the residue was dissolved in
DCM and filtered over a short pad of Celite, and the filtrate was
concentrated and purified by column chromatography on silica gel
using pentane/Et2O (95:5 to 90:10) as eluent to afford ( )-15 (29
mg, 28%) and ( )-16 (26 mg, 25%).
Methyl 2-Methyl-3-(propan-2-yl)-1H,2H,3H,4H-benzo[g]-
isoquinoline-3-carboxylate ( )-15. HRMS (ESI): m/z calcd for
[M + H]+ C19H24NO2 298.1802, found 298.1801. 1H NMR (400
MHz, CDCl3) δ: 7.75−7.69 (2H, m), 7.62 (1H, s), 7.46 (1H, s), 7.40−
7.33 (2H, m), 4.10 (1H, d (A part of AB pattern), J= 16.3), 3.77 (1H,
d (B part of AB pattern), J = 16.3), 3.60 (3H, s), 3.31 (1H, d (A part
of AB pattern), J = 16.3), 3.02 (1H, d (B part of AB pattern), J = 16.3),
2.58 (3H, s), 2.45 (1H, sept, J = 6.8), 1.06 (3H, d, J = 6.8), 1.00 (3H,
d, J = 6.8). 13C NMR (100 MHz, CDCl3) δ: 173.8, 133.0, 132.6, 132.2,
132.0, 127.3, 127.2, 126.5, 125.2, 125.1, 124.0, 68.6, 55.3, 51.1, 38.2,
31.3, 29.8, 18.0, 16.6.
Methyl 2-{1H,2H,3H,4H-Benzo[g]isoquinolin-2-yl}-3-methyl-
butanoate ( )-16. HRMS (ESI): m/z calcd for [M + H]+
C19H24NO2 298.1802, found 298.1803. 1H NMR (400 MHz,
CDCl3) δ: 7.74−7.69 (2H, m), 7.57 (1H, s), 7.50 (1H, s), 7.40−
7.35 (2H, m), 4.00−3.90. (2H, AB pattern, JAB = 16.3), 3.73 (3H, s),
3.10−3.02 (3H, m), 3.01 (1H, d, J = 10.8), 2.79 (1H, m), 2.27−2.16
(1H, m), 1.03 (3H, d, J = 6.8), 0.95 (3H, d, J = 6.8). 13C NMR (100
MHz, CDCl3) δ: 172.3, 134.2, 133.6, 132.4, 132.0, 127.3, 127.2, 126.8,
125.3, 125.3, 124.6, 74.4, 53.3, 50.8, 47.2, 30.4, 27.3, 20.0, 19.5.
Rearrangement of (S)-17. Compound (S)-17 (100 mg, 0.17
mmol) and GA-SBA-15 (24 mg, 0.03 mmol) were dissolved in
CH3CN (10 mL). The mixture was heated at 80 °C for 22 h. Then the
solvent was removed in vacuo, and the residue was purified by flash
chromatography on silica gel (pentane/dichloromethane, 50/50 to 0/
100). This led to (1S, 2S)-18 (38 mg, 38%) as a yellow oil and 19 (52
mg, 52%) as a yellow oil.
(2S,3R)-2-[(4-Methylbenzene)sulfonyl]-3-phenyl-5-oxa-7-
azatetracyclo[8.8.0.03,7.012,17]octadeca-1(18),10,12(17),13,15-
pentaen-6-one (21). ee = 84% (Chiralpak IB, hexane/EtOH/
chloroform 60/30/10, 1 mL/min, tR(2S, 3R) = 6.56 min, tR(2R, 3S) =
8.21 min, k(2S,3R) = 1.19, k(2R,3S) = 1.68, α = 1.41 and RS = 2.70).
[α]25 −103 (c 0.48, CHCl3). HRMS (ESI): m/z calcd for [M +
D
NH4]+ C29H29N2O4S 501.1843, found 501.1842. 1H NMR (400 MHz,
CDCl3) δ: 7.59 (1H, d, J = 8.0), 7.43−7.23 (10H, m), 7.15 (1H, tt, J =
8.3 and 1.5), 6.98 (1H, s), 6.91 (2H, d, J = 8.0), 5.72 (1H, d, J = 9.0),
5.19 (1H, s), 4.40 (1H, ddd, J = 14.3, 7.3 and 2.8), 4.25 (1H, br t, J =
14.0), 4.07 (1H, d, J = 9.0), 3.26 (1H, pseudo t, J = 13.0), 2.80 (1H, br
dd, J = 15.3 and 4.0), 2.12 (3H, s). 13C NMR (100 MHz, CDCl3) δ:
158.2, 144.9, 140.0, 138.1, 136.4, 135.8, 132.8, 131.4, 130.0, 129.5 (2 ×
C), 129.2 (2 × C), 128.8, 128.5 (2 × C), 128.3, 127.3, 127.0, 126.9,
126.1, 125.9 (2 × C), 77.8, 74.0, 67.7, 40.9, 35.8, 21.4. In full
agreement with the Chem-3D model showing a π-stacking interaction,
the stereochemistry was assigned from 2D NMR experiments. The
NOESY spectrum shows a clear cross-peaks between the signal of the
proton in position α to the tosyl group at 5.19 ppm and the s signal of
one aromatic proton of the naphthyl group at 6.98 ppm and the d of
one proton of the CH2O group of the carbamate ring at 5.72 ppm.
3-[2-(3-{[(4-Methylbenzene)sulfonyl]methyl}naphthalen-2-
yl)ethyl]-4-phenyl-2,3-dihydro-1,3-oxazol-2-one (22). HRMS
(ESI): m/z calcd for [M + NH4]+ C29H29N2O4S 501.1843, found
1
501.1840. H NMR (400 MHz, CDCl3) δ: 7.69−7.65 (2H, m), 7.54
(2H, d, J = 8.3), 7.51 (1H, s), 7.49−7.37 (6H, m), 7.23 (2H, d, J =
8.3), 7.13−7.09 (2H, m), 6.74 (1H, s), 4.28 (2H, s), 3.82−3.77 (2H,
m), 2.96−2.91 (2H, m), 2.42 (3H, s). 13C NMR (100 MHz, CDCl3)
δ: 156.1, 145.0, 135.5, 134.5, 133.5, 132.8, 132.2, 129.9, 129.8 (2 × C),
129.7, 129.4, 129.3 (2 × C), 128.8 (2 × C), 128.6 (2 × C), 127.8,
127.2, 127.1, 126.3, 126.3, 124.7, 123.9, 59.3, 43.0, 31.8, 21.8.
Rearrangement of (S)-20. (S)-20 (200 mg, 0.41 mmol) and GA-
SBA-15 (58 mg, 0.08 mmol) were dissolved in benzene (20 mL). The
mixture was heated at 80 °C for 16.5 h. The solvent was removed in
vacuo, and the residue was purified by flash chromatography on silica
gel (pentane/AcOEt, 80/20 to 50/50). This led to (2R,3S)-21 (54 mg,
27%) as a yellow amorphous solid and 22 (98 mg, 49%) as a yellow
amorphous solid.
Methyl (1S,2S)-2-Methyl-1,3-bis[(4-methylbenzene)-
sulfonyl]-1H,2H,3H,4H,5H-naphtho[2,3-d]azepine-2-carboxy-
late (18). ee = 56% (Chiralpak IC, hexane/EtOH 50/50, 1 mL/min,
tR(1S,2S) = 15.80 min, tR(1S,2S) = 28.43 min, k(1R,2R) = 4.27,
k(1R,2S) = 8.45, α = 1.98, RS = 7.05). [α]25 +23 (c 0.6, CHCl3).
D
HRMS (ESI): m/z calcd for [M + NH4]+ C31H35N2O6S2 595.1931,
found 595.1928. 1H NMR (400 MHz, CDCl3) δ: 7.73 (1H, d, J = 8.0),
7.62 (1H, s), 7.47 (2H, d, J = 8.3), 7.41 (1H, dt, J= 1.0 and 6.8), 7.33−
7.29 (3H, m), 7.22 (1H, d, J = 8.0), 7.11 (2H, d, J = 8.0), 7.05 (2H, d,
J = 8.0), 6.68 (1H, s), 5.95 (1H, s), 4.11 (1H, ddd, J = 6.8, 11.8 and
14.8), 3.92−3.80 (2H, m), 3.62 (3H, s), 3.00 (1H, ddd, J = 1.8, 5.3 and
14.8), 2.55 (3H, s), 2.35 (3H, s), 2.32 (3H, s). 13C NMR (100 MHz,
CDCl3) δ 172.5, 145.7, 142.8, 139.3, 136.2, 135.9, 135.7, 133.7, 131.7,
129.3, 129.3 (2 × C), 129.22 (2 × C), 129.21 (2 × C), 129.0, 127.7,
127.1, 126.8, 126.4 (2 × C), 125.7, 78.4, 66.6, 53.4, 45.4, 33.0, 23.3,
21.6, 21.5. The cis stereochemistry was assigned from 2D NMR
experiments. The NOESY spectrum shows a clear cross-peak between
(2R,3S)-2-[(4-Methylbenzene)sulfonyl]-3-phenyl-5-oxa-7-
azatetracyclo[8.8.0.03,7.012,17]octadeca-1(18),10,12(17),13,15-
pentaen-6-one (21). ee = 77% (Chiralpak IB, hexane/EtOH/
chloroform 60/30/10, 1 mL/min, tR(2S,3R) = 6.56 min, tR(2R,3S) =
8.21 min, k(2S,3R)= 1.19, k(2R,3S) = 1.68, α = 1.41 and RS = 2.70).
[α]25 +118 (c 0.45, CHCl3).
D
2781
dx.doi.org/10.1021/jo202580y | J. Org. Chem. 2012, 77, 2773−2783